Researchers are under pressure to accelerate their studies and obtain faster, more predictable results that can speed time to market with efficacious therapeutics. But the complex genetically engineered models that are vital to their studies have traditionally required lengthy design and development timelines. In this podcast hosted by Drug Discovery World, Dominique Bröhl and Jan Evert-Uringa, Scientific Program Managers at Taconic Biosciences, review challenges and solutions to accelerating mouse model generation without sacrificing quality. Listeners will learn how a solution like Taconic's ExpressMODEL® platform overcomes the limitations of natural breeding, allows for more predictable timelines, maximizes the reliability and effectiveness of downstream breeding by accurately selecting founder mice with high germline transmission and fertilization rates, and ultimately enables investigators to obtain a larger cohort of mice on a faster timeline: